代表性论著、科研获奖、人才称号 |
一、代表性论著 1.Chen H, Huang L, Luo X, et al. Programmable DNA nanostructure-based self-powered biosensor for point-of-care opportunistic pathogens detection[J]. Sensors and Actuators B: Chemical, 2025: 139063.（共同通讯作者） 2.Xu J, Chen H, Tao Y, et al. A Dual‐Target Recognition System Based on Acid‐Degradable Ni‐MOF and Aptamer Guidance for Precise Tumor Diagnosis and Combined Therapy[J]. Advanced Science, 2025, 12(42): e12838.（共同通讯作者） 3.Lv Y, Ma Z, Chong Y, et al. Illuminating liver fibrosis: recent progress in the design and applications of highly sensitive fluorescent probes[J]. Materials Horizons, 2025.（共同通讯作者） 4.Su X, Chen F, Shi Z, et al. Global burden and health inequalities of sex chromosomal DSDs (1990–2021): a GBD 2021 analysis[J]. International Urology and Nephrology, 2026, 58(2): 483-499.（通讯作者） 5.Xu J, Chen H, Wang Z, et al. Multi-recognition sites and integrated self-powered chip: Trifurcated DNA hairpin circular walker in cancer biomarker detection[J]. International Journal of Biological Macromolecules, 2025: 146063.（共同通讯作者） 6.Yan Y, Sun Y, Li Y, et al. Advancing cancer therapy: Nanomaterial-based encapsulation strategies for enhanced delivery and efficacy of curcumin[J]. Materials Today Bio, 2025, 33: 101963.（共同通讯作者） 7.Su X, Chen F, Shi Z, et al. Global insight of early-onset genitourinary cancers in adolescents and adults from 1990 to 2021: temporal trends and health inequalities analyses[J]. World Journal of Surgical Oncology, 2025, 23(1): 208.（共同通讯作者） 8.Su X, Tao Y, Chen F, et al. Trends in the global, regional, and national burden of bladder cancer from 1990 to 2021: an observational study from the global burden of disease study 2021[J]. Scientific reports, 2025, 15(1): 7655.（共同通讯作者） 9.Xue, Li; Hecheng; Chen, Qi; Wang, Zhenlong; Zhang, Peng; Chen, Haiwen; Wang, Ziming; Chong, Tie; Inhibition of Recombining Binding Protein Suppressor of Hairless (RBPJ) Impairs the Growth of Prostate Cancer.,Cellular Physiology and Biochemistry, 2015, 36(5): 1982-1990. (唯一第一作者) 10.Xue, Li; Zhu, Zhen; Wang, Ziming; Li, Hecheng; Zhang, Peng; Wang, Zhenlong; Chen, Qi; Chen, Haiwen; Chong, Tie; Knockdown of prostaglandin reductase 1 (PTGR1) suppresses prostate cancer cell proliferation by inducing cell cycle arrest and apoptosis,Bioscience Trends, 2016, 10(2): 133-139. (共同第一作者) 11.Xue, Li; Wang, Zhenlong; Li, Hecheng; Li, Zhaolun; Chen, Qi; Zhang, Peng; Chen, Haiwen; Wang, Ziming; Chong, Tie; RBPJ contributes to acquired docetaxel resistance in prostate cancer cells,Molecular & Cellular Toxicology, 2017, 13(3): 279-285. (唯一第一作者) 12.Zhu, Zhen; Ling, Lanlan; Qi, Lezhong; Chong, Yue;Xue, Li; Bruton's Tyrosine Kinase (BTK) Inhibitor (Ibrutinib)-Suppressed Migration and Invasion of Prostate Cancer,OncoTargets and Therapy, 2020, 13(39): 4113-4122. (唯一通讯作者) 13.Tianyuan Zhai; Meng Dou; Yubo Ma; Hong Wang; Fang Liu; Liandong Zhang; Tie Chong; Ziming Wang;Xue, Li; Lipid metabolism-related miRNAs with potential diagnostic roles in prostate cancer,Lipids in Health and Disease, 2023, 22(39). (共同通讯作者) 14.此外，多篇研究成果发表于Nature Communications、Science Advances等国际权威期刊，累计发表SCI论文40余篇。 二、科研获奖 1.陕西省科技进步二等奖（第一完成人）。 三、专利成果 1.发明/实用新型专利：一种导电光热自愈合复合水凝胶敷料及制备方法和应用，中国，CN202010218233.4。 2.实用新型专利：一种膀胱清血器，中国，201720800568.0。 3.实用新型专利：一种局部麻醉用的穿刺针，中国，ZL 2021 2 0032986.6。 4.创新成果：新型DVC处置系统、免缝合膀胱尿道磁吻合等数项创新成果。 四、人才称号 1.2023年度中华医学会泌尿外科分会（CUA）“青秀人才”。 |
